Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Investigative Dermatology|February 2, 2008
Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsivenessEmma Guttman-Yassky, Yulia Vugmeyster, Michelle A Lowes, et al.
Nature Genetics|November 11, 2003
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasisCynthia Helms, Li Cao, James G Krueger, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2005
Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)Michelle A Lowes, Francesca Chamian, Maria Veronica Abello, et al.
Pageof 2